Matt Gline, the founder of SoftBank-backed Roivant Sciences, a biotechnology company, said he will be stepping down from the office of the chief executive officer.

The company’s Chief Financial Officer (CFO) Vivek Ramaswamy will step into the role of executive chairman with Matt Gline assuming the role of the CFO.

In a letter to the company’s shareholders, Ramaswamy said, the move would “separate my increasing public engagement from Roivant’s day-to-day operations”.

Incidentally, Japan’s Sumitomo Dainippon Pharma Co has a 10% stake in Roivant.

Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: biotechnology, biotechnology company, CFO, Chief Financial Officer, Executive Chairman, founder, HR, HRM, human resources, management, Matt Gline, Roivant Sciences, shareholders, SoftBank backed, stepping down, Vivek Ramaswamy